Avidity Biosciences, Inc. (DELISTED) (RNAM:DL)
72.82
0.00 (0.00%)
USD |
NASDAQ |
Mar 06, 16:00
Avidity Biosciences EPS Diluted (Quarterly) : -1.588 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Dyne Therapeutics, Inc. | -0.7584 |
| Biogen, Inc. | -0.3333 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Insmed, Inc. | -1.538 |
| Revolution Medicines, Inc. | -1.855 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -237.10M |
| Revenue (Quarterly) | 0.86M |
| Total Expenses (Quarterly) | 237.96M |
| Enterprise Value | 9.650B |
| Gross Profit Margin (Quarterly) | -73.95% |
| Profit Margin (Quarterly) | -27.57K% |
| Earnings Yield | -6.82% |
| Normalized Earnings Yield | -6.815 |